CTXR
Citius Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.24M
P/E Ratio
—
EPS
$-2.46
Beta
1.38
52W High
$2.48
52W Low
$0.63
50-Day MA
$0.79
200-Day MA
$1.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.51
PEG Ratio
0.00
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Fundamentals
| Revenue (TTM) | $3.94M |
| Gross Profit (TTM) | $3.15M |
| EBITDA | $-36.36M |
| Operating Margin | -214.10% |
| Return on Equity | -47.80% |
| Return on Assets | -17.70% |
| Revenue/Share (TTM) | $0.27 |
| Book Value | $3.57 |
| Price-to-Book | 0.24 |
| Price-to-Sales (TTM) | 4.88 |
| EV/Revenue | 3.351 |
| EV/EBITDA | -2.74 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $22.38M |
| Float | $21.88M |
| % Insiders | 2.20% |
| % Institutions | 7.69% |
Analyst Ratings
Consensus ($6.00 target)
1
Buy1
HoldData last updated: 4/7/2026